Upload
digital-for-academy
View
265
Download
3
Embed Size (px)
Citation preview
Integrazione alimentare nellepatologie neuro-degenerative
I MILLE VOLTI DELLA NUTRIZIONEUniversità degli Studi di Milano - Bicocca | Auditorium ‘Guido Martinotti’
www.digitalforacademy.com
Marco Marchetti
?
Alzheimer: ogni anno si spende oltre l'1% del Pil mondiale
Rapporto Mondiale Alzheimer. Ogni 3 secondi un caso di demenza nel Mondo. Oltre la
metà sono di Alzheimer. In Italia ci sono 1.241.000 persone con demenza. L’Alzheimer
rappresenta circa il 50-60% delle demenze complessive.
In tutto il mondo sono 35,6 milioni i malati di demenza. Un numero destinato a raddoppiare
nel 2030 e a triplicare nel 2050. Sono queste le cifre preoccupanti contenute nel Rapporto
mondiale Alzheimer 2010 che lancia l’allarme pandemia sulla malattia. Un epidemia
inarrestabile che raggiunge costi sociali economici pari a 604 mld di dollari: oltre l’1% del
Pil mondiale.
"Se la cura della demenza fosse una nazione – hanno sottolineato nel Report Anders Wimo
(Karolinska Institute di Stoccolma) e Martin Prince (Istituto di psichiatria del King's College
di Londra) – sarebbe la 18esima al mondo per valore economico".
Nel 'Vecchio Continente' sono 7,3 milioni i pazienti affetti dalla malattia, e diventeranno 14,6
milioni nel 2040. Un milione solo in Italia, tra i 100-120 mila in Lombardia.
le famiglie italiane colpite spendono oltre 9 miliardi di euro per pagare badanti o altro
personale da dedicare all'assistenza del proprio caro.
How many dementia cases in the future?
6
Toward defining the preclinical stages of Alzheimer’s disease:
Recommendations from the National Institute on Aging and the Alzheimer’s
Association workgroup
Crawford MA, et al. Evidence for the unique
function of docosahexaenoic acid during the
evolution of the modern hominid brain. Lipids
1999;34 (Suppl):39–47.
Mediterranean Diet, Alzheimer Disease, and Vascular MediationNikolaos Scarmeas, Yaakov Stern, Richard Mayeux, Jose A. Luchsinger.
Arch Neurol. 2006;63:1709-1717
Higher adherence to the MeDi is associated
with a reduced risk for AD. The association
does not seem to be mediated by vascular
comorbidity. This could be the result of other
biological mechanisms (oxidative or
inflammatory) being implicated.
Key Features of Traditional
Okinawa Diet
1) Low Caloric Density (plant-based, low fat, moderate protein from soy, fish, lean meats)
2) High Nutrient Density (Vitamins A,C, E, potassium, magnesium, folate, and healthy oils)
3) Phyto-nutrient Rich (polyphenols, carotenoids mostly from green leafy, yellow root vegetables and seaweed)
4) Low in Glycemic Load (high quality carbohydrates from staple sweet potato)
5) Anti-inflammatory (CR, polyphenols, omega 3 fatty acids)
Ipomoera batatas
cultivar Ayamurasaki
Curcuma longa
Curcumin Anthocyanin
Healthy aging diets other than the Mediterranean: A focus on the Okinawan diet.
Willcox DC, Scapagnini G, Willcox BJ. Mech Ageing Dev. 2014 Jan 21.
Wakame
Undaria pinnatifida
Phlorotannin
Scapagnini G, Colombrita C, Amadio M, D'Agata V, Arcelli E, Sapienza M,
Quattrone A, Calabrese V.
Curcumin activates defensive genes and protects neurons against
oxidative stress. Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):395-403. Institute of Neurological Sciences, National Research Council (CNR), Catania, Italy.,
Blanchette Rockefeller Neurosciences Institute, West Virginia University, Rockville, Maryland.
CURCUMIN
heme oxygenase 1
ferritin
thioredoxin
GSH transferases
UDP-glucoronosyltransferases
NAD(P)H:quinone oxidoreductase 1
-glutamylcysteine synthetase
GSH-reductase
catalase
biliverdin/bilirubinCO
Fe
GSH synthesis
regeneration of ubiquinol and tocopherol
regeneration of GSH and dehydroascorbate
multifunctional roles
regeneration of oxidized thioredoxinand dehydroascorbate
AN
TIO
XID
AN
T A
ND
CY
TOP
RO
TEC
TIV
E A
CTI
ON
Phase 2 Response Phase 2 ResponseNrf2/keap1/ARE CytoprotectionPhase 2 Response
AN
TIO
XID
AN
T R
ESP
ON
SIV
E EL
EMEN
T (A
RE)
O
OR2
HO
OH
OH
R1
HO
Keap1
Nrf2
antioxidant
NFkBNrf2Keap1 IkB
Inflammation Inflammation
Nrf2 NFkB
Defensive ResponseDetox enzymes type II
HO-1
Inflammatory ResponseCytokines
NOSCOX
DNA
OxidativeStress
Curcumin OxidativeStress
Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, and Ganguli
M. Incidence of Alzheimer's disease in a rural community in India: the Indo-US
study. Neurology 57: 985-989, 2001.
Muthane U, Yasha TC, and Shankar SK. Low numbers and no loss of melanized
nigral neurons with increasing age in normal human brains from India.
Ann Neurol 43: 283-287, 1998.
Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. Curry consumption and
cognitive function in the elderly. Am J Epidemiol 164(9):898-9, 2006
Epidemiological studies showed that in India, where curcumin is widely used
in daily diet, there is a reduced age-adjusted prevalence of AD (in patients
between 70 and 79 years of age is 4.4 fold less than that of the United
States), as well as a lower prevalence of Parkinson’s disease.
Proc Natl Acad Sci U S A. 2007 July 31; 104(31): 12849–12854.
Innate immunity and transcription of MGAT-III and
Toll-like receptors in Alzheimer's disease patients
are improved by bisdemethoxycurcumin
Fiala M. et al.Department of Medicine, Greater Los Angeles Veteran's Affairs
Medical Center
J Clin Psychopharmacol. 2008 Feb;28(1):110-3.
Six-month randomized, placebo-controlled, double-
blind, pilot clinical trial of curcumin in patients with
Alzheimer disease.
Baum L. et al
Delphinidin
Low bioavailability Better bioavailability
Epicatechin
Blueberry
Cocoa
(Theobroma cacao)
Polyphenols bioavailability is a critical aspect
In a controlled randomized trial, healthy 50–69-year-old
subjects consumed either a high or low cocoa flavanol–
containing diet for 3 months. A high-flavanol intervention
was found to enhance DG function, as measured by fMRIand by cognitive testing.
Cocoa epicatechins improve cognition
The Connection Between Fats and Heart Diseases
1969, Bang & Dyerberg: investigation in Greenlandnear absence of thrombotic heart diseases inGreenlanders
37
Homotaurine Reduces Amyloid Deposition in hAPPTransgenic Mouse Brain
RS
CC
RS
CC
(8 weeks of treatment)
Control (untreated) Homotaurine (100mg/kg/day)
Gervais F et al. Neurobiol Aging 2007; 28(4):537-47.
38
Studies N Population Duration Endpoints
10 Phase I 288 Healthy 7-10 days Safety/PK
Phase II 58 AD 3 monthsCognitive function,
Amyloid Aβ CSF level
Phase II Open-label extension
42 AD 41 months Cognitive function
Phase II 24Cerebral Amyloid
Angiopathy3 months
Neurological function, cognitive function
Phase III North America
1,052 AD 18 monthsCognitive function,
brain volume
Phase III North America Open-label
extension738 AD 12 months Cognitive function
Phase III Europe 975 AD 18 monthsCognitive function,
brain volume
16 Clinical Trials Involving > 2,000 Subjects
AiguoWu a, Emily E. Noble a, Ethika Tyagi a, Zhe Ying a, Yumei Zhuang a, Fernando
Gomez-Pinilla
Biochimica et Biophysica Acta (2014)
Synergy research: Approaching a new generation of nutraceuticals
www.digitalforacademy.com | [email protected]